Singapore Exchange (SGX) today welcomed HC Surgical Specialists Limited (HC Surgical Specialists) to Catalist under the stock code “1B1”.
HC Surgical Specialists is a medical services group primarily engaged in the provision of endoscopic procedures, including gastroscopies and colonoscopies, and general surgery services with a focus on colorectal procedures, across a network of 10 clinics in Singapore.
Dr Heah Sieu Min, Consultant Surgeon, Chief Executive Officer and Executive Director of HC Surgical Specialists, said, “I am proud to be part of HC Surgical Specialists’ Catalist listing. In addition to centrally located clinics, we operate several private endoscopy centres in the heartlands of Singapore, where a significant proportion of our population reside. The diseases that we treat, among others, include colorectal cancer, stomach cancer and haemorrhoids. Early detection of diseases via endoscopy, provides a greater chance of cure. We are committed to making quality healthcare accessible to a broader consumer base in the heartlands, thereby literally bringing ‘specialist healthcare to your doorstep’.”
Mohamed Nasser Ismail, Head of Equity Capital Market (SME) and Head of Capital Market Development, SGX, said, “We are delighted to welcome the listing of HC Surgical Specialists, a home grown private healthcare specialist in the area of endoscopic and colorectal healthcare. The group has established significant presence in Singapore, and we look forward to supporting the company as it looks to expand its business overseas.”
The listing of HC Surgical Specialists brings the total number of companies on Catalist to 185, with a combined market capitalisation of $10 billion, and the total number ofhealthcare-related companies, Real Estate Investment Trusts and Business Trusts listed on both SGX Mainboard and Catalist to 33, with a combined market capitalisation of more than $30 billion.
HC Surgical Specialists opened at $0.55 today.
